Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1285

1.

Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.

Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, Unemo M.

N Engl J Med. 2016 Jun 23;374(25):2504-6. doi: 10.1056/NEJMc1512757. No abstract available.

2.

[Against tripper soon almost no herb is effective].

Oberhofer E.

MMW Fortschr Med. 2016 Jun 9;158 Suppl 1:12. doi: 10.1007/s15006-016-8318-6. German. No abstract available.

PMID:
27259894
3.

Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.

Liang JY, Cao WL, Li XD, Bi C, Yang RD, Liang YH, Li P, Ye XD, Chen XX, Zhang XB.

BMC Infect Dis. 2016 Apr 14;16:152. doi: 10.1186/s12879-016-1469-3.

4.

Antimicrobial resistance in Neisseria gonorrhoeae in China: a meta-analysis.

Chen Y, Gong Y, Yang T, Song X, Li J, Gan Y, Yin X, Lu Z.

BMC Infect Dis. 2016 Mar 3;16:108. doi: 10.1186/s12879-016-1435-0.

5.

Increasing Incidence of High-Level Tetracycline-Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import.

Lee H, Kim H, Kim HJ, Suh YH, Yong D, Jeong SH, Lee K, Chong Y.

Yonsei Med J. 2016 Mar;57(2):350-7. doi: 10.3349/ymj.2016.57.2.350.

6.

Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.

Lahra MM, Enriquez RP; National Neisseria Network..

Commun Dis Intell Q Rep. 2015 Dec 31;39(4):E628-30. No abstract available.

7.

New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.

Lee H, Lee K, Chong Y.

Expert Rev Anti Infect Ther. 2016;14(2):243-56. doi: 10.1586/14787210.2016.1134315. Review.

PMID:
26690658
8.

New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan.

Deguchi T, Yasuda M, Hatazaki K, Kameyama K, Horie K, Kato T, Mizutani K, Seike K, Tsuchiya T, Yokoi S, Nakano M, Yoh M.

Emerg Infect Dis. 2016 Jan;22(1):142-4. doi: 10.3201/eid2201.150868. No abstract available.

9.

Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.

Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Drews S, Horsman G, Wylie J, Haldane D, Garceau R, Ratnam S, Wong T, Archibald C, Mulvey MR.

Emerg Infect Dis. 2016 Jan;22(1):65-7. doi: 10.3201/eid2201.151247.

10.

[MOLECULAR MECHANISMS OF DRUG RESISTANCE NEISSERIA GONORRHOEAE HISTORY AND PROSPECTS].

Bodoev IN, Il'ina EN.

Mol Gen Mikrobiol Virusol. 2015;33(3):22-7. Review. Russian.

PMID:
26665738
11.

Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use?

Low N, Unemo M.

Curr Opin Infect Dis. 2016 Feb;29(1):45-51. doi: 10.1097/QCO.0000000000000230. Review.

PMID:
26658656
12.

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.

Kirkcaldy RD, Hook EW 3rd, Soge OO, del Rio C, Kubin G, Zenilman JM, Papp JR.

JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347. No abstract available.

13.

Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling.

Grad YH, Goldstein E, Lipsitch M, White PJ.

J Infect Dis. 2016 Mar 15;213(6):883-90. doi: 10.1093/infdis/jiv517. Review.

PMID:
26518045
14.

Gonococcal infections in Austria: a long-term observation of prevalence and resistance profiles from 1999 to 2014.

Stary A, Heller-Vitouch C, Binder M, Geusau A, Stary G, Rappersberger K, Komericki P, Hoepfl R, Haller M.

J Dtsch Dermatol Ges. 2015 Nov;13(11):1136-45. doi: 10.1111/ddg.12816.

PMID:
26513072
15.

Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).

Su XH, Wang BX, Le WJ, Liu YR, Wan C, Li S, Alm RA, Mueller JP, Rice PA.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):621-3. doi: 10.1128/AAC.01211-15.

16.

First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.

Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS.

J Antimicrob Chemother. 2016 Jan;71(1):92-9. doi: 10.1093/jac/dkv321.

PMID:
26472770
17.

The prevalence and epidemiology of plasmid-mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates in Guangzhou, China, 2002-2012.

Zheng H, Wu X, Huang J, Qin X, Xue Y, Zeng W, Lan Y, Ou J, Tang S, Fang M.

BMC Infect Dis. 2015 Oct 9;15:412. doi: 10.1186/s12879-015-1148-9.

18.

Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.

Shimuta K, Watanabe Y, Nakayama S, Morita-Ishihara T, Kuroki T, Unemo M, Ohnishi M.

BMC Infect Dis. 2015 Sep 17;15:378. doi: 10.1186/s12879-015-1110-x.

19.

Update on Treatment Options for Gonococcal Infections.

Lancaster JW, Mahoney MV, Mandal S, Lawrence KR.

Pharmacotherapy. 2015 Sep;35(9):856-68. doi: 10.1002/phar.1627. Review.

PMID:
26343813
20.

Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012.

Sawatzky P, Liu G, Dillon JA, Allen V, Lefebvre B, Hoang L, Tyrrell G, Van Caeseele P, Levett P, Martin I.

J Clin Microbiol. 2015 Nov;53(11):3646-9. doi: 10.1128/JCM.02303-15.

Items per page

Supplemental Content

Loading ...
Support Center